Schlagwörter
Adult
6
Antibodies
6
Artificial
6
Belgium
6
COVID-19
6
Clinical Trials
6
Convalescent plasma
6
Humans
6
Immunization
6
Intensive Care Units
6
Mechanical ventilation
6
Multicenter Studies as Topic
6
Passive
6
Phase II as Topic
6
Randomized
6
Randomized Controlled Trials as Topic
6
Respiration
6
Respiratory failure
6
Severe Acute Respiratory Syndrome
Time Factors
6
Treatment Outcome
6
Viral